From: Role of zinc in severe pneumonia: a randomized double bind placebo controlled study
Outcome | Zinc n = 64 | Placebo n =53 | P |
---|---|---|---|
Duration of hospitalization (hours) | 73.5 (49.5,107.5) | 72 (48.0,87.7) | 0.193* |
Duration of severe pneumonia (hours) | 34.2 (21.0,48.0) | 26 (16.0,46.0) | 0.219* |
Duration of pneumonia (hours) | 40 (24,54.2) | 43 (18.5,72.0) | 0.943* |
Duration of nil-per-orally (hours) | 10 (0.0,23) | 12 (0.0,18) | 0.771* |
Duration of intravenous fluid (hours) | 22.0 (12.0,31.0) | 16 (1.5,32.5) | 0.258* |
Duration of oxygen use (hours) | 10 (0.0,22.0) | 11.0 (0.0,23.5) | 0.684* |
Treatment failure requiring 2nd line drugs | 14 (21.9%) | 15 (28.3%) | 0.423** |
Treatment failure requiring 3rd line drugs | 1 (1.6%) | 1 (1.9%) | 0.893** |